Search Results
Olaparib Maintenance Retreatment in Epithelial Ovarian Cancer
Dr. Willmott on FDA Approval of Maintenance Olaparib in Ovarian Cancer
The Impact of PAOLA-1 on Frontline Treatment of Ovarian Cancer
SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated advanced ovarian cancer
PAOLA-1: Combination Maintenance Therapy in Ovarian Cancer
Dr. Chon on Challenges With Maintenance Therapy in Ovarian Cancer
SOLO1 trial of maintenance olaparib in advanced ovarian cancer | Susana Banerjee
Toxicities Associated With Rucaparib for the Treatment of Ovarian Cancer
Maintenance Olaparib Following Platinum-Based Chemotherapy for Newly Diagnosed Ovarian Cancer
Final Overall Survival Results From the Phase 3 SOLO2 Trial for Ovarian Cancer
ATHENA Trial: Post Adjuvant Chemo in Ovarian Cancer | Premal Thaker, MD, MS | ASCO22 GYN Updates
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches